Seaport Therapeutics
Industry
- Biotechnology
- Large Molecule
- Pharmaceuticals
- Vaccines
See more in Biomedtracker
Latest on Seaport Therapeutics
In Vivo
• By Deanna Kamienski and Maureen Riordan
Biopharma financing during the fourth quarter of 2024 totaled $16.8bn from 251 deals. Of those, 60 reached $100m or more. The follow-on public offering (FOPO) and venture financing categories tied for
Scrip
• By Mandy Jackson
Venture capital fundraising by biopharmaceutical companies rose to $7.11bn in the fourth quarter of 2024, after falling to $6.46bn in Q3 from $7.95bn in Q2, according to data from Evaluate. But the ye
Scrip
• By Mandy Jackson
PureTech Health plc, after the multibillion-dollar success of its last neuropsychiatry venture Karuna Therapeutics Inc., launched Seaport Therapeutics in April with $100m in series A funding and on 21